CPH 0.00% 0.9¢ creso pharma limited

This is where we differ, again as I previously posted, an ASX...

  1. 1,953 Posts.
    lightbulb Created with Sketch. 187
    This is where we differ, again as I previously posted, an ASX company's individual SP's will rise and be sustained when revenue is realised. License announcements are momentary catalysts, and force a transient spike in a SP. One needs to think how long until facilities, cultivation, testing and distribution will take place with Australian companies. Years?

    I have only invested money into companies that are not, in the short term, chasing elusive licenses to cultivate in Australia. The likes of MMJ and CPH have available products just waiting for final distribution permits. This equates to near term revenue and immediate market share.

    As always, do your own research.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.